Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Prolactin and human breast cancer: a review.

× No keyword cloud information.

9 in total

1. Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer.

Authors: A Manni; A E Boucher; L M Demers; H A Harvey; A Lipton; M A Simmonds; M Bartholomew
Journal: Breast Cancer Res Treat Date: 1989-12 Impact factor: 4.872

2. Isolation and characterization of a serially cultivated, neoplastic, epithelial cell line from the N-nitrosomethylurea induced rat mammary adenocarcinoma.

Authors: L A Cohen
Journal: In Vitro Date: 1982-06

3. Breast cancer in a male patient with prolactinoma.

Authors: S Haga; O Watanabe; T Shimizu; T Iida; H Imamura; T Kajiwara; M Fujibayashi
Journal: Surg Today Date: 1993 Impact factor: 2.549

4. Isolation of cleaved prolactin variants that stimulate DNA synthesis in specific cell types in rat pituitary cell aggregates in culture.

Authors: M Andries; D Tilemans; C Denef
Journal: Biochem J Date: 1992-01-15 Impact factor: 3.857

5. Influence of L-thyroxine, L-triiodothyronine, thyroid stimulating hormone, or estradiol on the cell kinetics of cultured mammary cancer cells.

Authors: Y de Launoit; R Kiss
Journal: In Vitro Cell Dev Biol Date: 1989-07

6. The biological activity of a single dose of tamoxifen in the adult ovariectomized rat.

Authors: S P Bowman; C A Jones; A Leake; I D Morris
Journal: Br J Pharmacol Date: 1983-04 Impact factor: 8.739

7. Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study.

Authors: S De Placido; C Gallo; F Perrone; A Marinelli; C Pagliarulo; C Carlomagno; G Petrella; M D'Istria; G Delrio; A R Bianco
Journal: Br J Cancer Date: 1990-10 Impact factor: 7.640

8. Prognostic significance of serum prolactin levels in advanced breast cancer.

Authors: M Dowsett; G E McGarrick; A L Harris; R C Coombes; I E Smith; S L Jeffcoate
Journal: Br J Cancer Date: 1983-06 Impact factor: 7.640

9. Circulating levels of testosterone, 17 beta-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients.

Authors: G Secreto; C Recchione; A Cavalleri; M Miraglia; V Dati
Journal: Br J Cancer Date: 1983-02 Impact factor: 7.640

9 in total